Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 10(19), p. e216, 2019
DOI: 10.1016/j.clml.2019.09.359
Elsevier, Biology of Blood and Marrow Transplantation, 7(25), p. 1312-1319, 2019
DOI: 10.1016/j.bbmt.2019.03.016
Links
Tools
A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study
Journal article published in 2019 by
Park Ss,
Kihyun Kim,
Sung Soo Yoon,
K. Kim 
,
Sung-Soo Park ,
Kim Sj,
Seok-Jin Kim,
Lee Jh,
Jae Hoon Lee,
Yoon Ss,
Mun Yc,
Yeung Chul Mun,
Lee Jj,
Je-Jung Lee,
Eom Hs
and other authors.
,
Sung-Soo Park ,
Kim Sj,
Seok-Jin Kim,
Lee Jh,
Jae Hoon Lee,
Yoon Ss,
Mun Yc,
Yeung Chul Mun,
Lee Jj,
Je-Jung Lee,
Eom Hs
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 